Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Rafael Holdings Inc's Business Segments
Rafael Holdings Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q2 FY2025
Reportable Segments
-
Largest Segment
-
Total Revenue
$ 0
Regions Reported
-
Rafael Holdings Inc does not report a distinct business-segment axis in its filings - its disaggregated revenue is disclosed by product and service category instead. See the Product & Service breakdown below.
Revenue by Product & Service Category - Q2 FY2025
- Rental Third Party62.3%
- Rental Related Party37.7%
- Product Revenue0%
- Infusion Technology0%
Revenue by Product & Service Category - Q2 FY2025
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Rental Third Party | $ 0 | 62.3% |
| Rental Related Party | $ 0 | 37.7% |
| Product Revenue | - | 0% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
1 more categories available
Sign in to unlock the full Rafael Holdings Inc dataset.
Description of Rafael Holdings Inc
Rafael Holdings Inc is a diversified holding company that engages in various businesses, primarily in the healthcare, real estate, and technology sectors. The company is headquartered in Newark, New Jersey, and was founded in 199
In the healthcare sector, Rafael Holdings operates through its subsidiary, Rafael Pharmaceuticals Inc. Rafael Pharmaceuticals is a clinical-stage, oncology-focused pharmaceutical company that develops and commercializes therapies for cancer patients. The company primarily focuses on developing drugs that target the processes of cancer cells to kill and inhibit their growth, with the goal of providing more effective and less toxic treatments for patients.
In addition to its healthcare business, Rafael Holdings also has a significant presence in the real estate sector. The company owns and operates various real estate properties primarily in Newark, New Jersey, including commercial office buildings and industrial properties. The real estate division of Rafael Holdings aims to utilize its properties to generate stable rental income and capital appreciation over the long term.
Furthermore, Rafael Holdings has a technology division that focuses on investments in early-stage technology companies. The company seeks to identify and invest in innovative technologies with high growth potential. These investments can include startups in various industries such as healthcare, life sciences, and information technology. By investing in these companies, Rafael Holdings aims to maximize the value of its technology portfolio and generate significant returns for its shareholders.
Rafael Holdings is led by an experienced management team with extensive expertise in the healthcare, real estate, and technology sectors. The company's management team is dedicated to identifying and pursuing growth opportunities across its various business segments.
Overall, Rafael Holdings Inc is a diversified holding company that operates in the healthcare, real estate, and technology sectors. Through its subsidiary, Rafael Pharmaceuticals, the company is focused on developing innovative cancer therapies. Additionally, Rafael Holdings owns and operates a portfolio of real estate properties and invests in early-stage technology companies.
In the healthcare sector, Rafael Holdings operates through its subsidiary, Rafael Pharmaceuticals Inc. Rafael Pharmaceuticals is a clinical-stage, oncology-focused pharmaceutical company that develops and commercializes therapies for cancer patients. The company primarily focuses on developing drugs that target the processes of cancer cells to kill and inhibit their growth, with the goal of providing more effective and less toxic treatments for patients.
In addition to its healthcare business, Rafael Holdings also has a significant presence in the real estate sector. The company owns and operates various real estate properties primarily in Newark, New Jersey, including commercial office buildings and industrial properties. The real estate division of Rafael Holdings aims to utilize its properties to generate stable rental income and capital appreciation over the long term.
Furthermore, Rafael Holdings has a technology division that focuses on investments in early-stage technology companies. The company seeks to identify and invest in innovative technologies with high growth potential. These investments can include startups in various industries such as healthcare, life sciences, and information technology. By investing in these companies, Rafael Holdings aims to maximize the value of its technology portfolio and generate significant returns for its shareholders.
Rafael Holdings is led by an experienced management team with extensive expertise in the healthcare, real estate, and technology sectors. The company's management team is dedicated to identifying and pursuing growth opportunities across its various business segments.
Overall, Rafael Holdings Inc is a diversified holding company that operates in the healthcare, real estate, and technology sectors. Through its subsidiary, Rafael Pharmaceuticals, the company is focused on developing innovative cancer therapies. Additionally, Rafael Holdings owns and operates a portfolio of real estate properties and invests in early-stage technology companies.
Rafael Holdings Inc. operates primarily in the biotechnology and real estate sectors, facilitating a diverse portfolio of offerings. Below is a comprehensive overview of the segments, products, and services provided by Rafael Holdings Inc.:
Biotechnology Segment
1. Therapeutics Development:
- Rafael Pharmaceuticals is a key component of the biotechnology segment, focusing on the development of innovative cancer treatments. The company emphasizes the use of metabolic therapies, particularly its lead drug candidate, which aims to leverage the unique metabolic processes of cancer cells to enhance therapeutic outcomes.
- The research and development pipeline includes various stages of clinical trials. The company invests in advanced therapeutic technologies targeting specific types of cancers, including pancreatic cancer and hematological malignancies.
2. Collaborations and Partnerships:
- Rafael Holdings often collaborates with academic institutions and research organizations. Such partnerships facilitate accelerated research and development processes, share expertise, and provide funding opportunities for emerging therapies.
3. Intellectual Property:
- The company holds a robust portfolio of patents covering its proprietary technologies and compounds. Intellectual property is crucial for protecting the innovations being developed and for securing competitive advantages in the biotechnology market.
Real Estate Segment
1. Real Estate Investment:
- Rafael Holdings maintains a strategic portfolio of commercial real estate properties. This includes office buildings and other facilities, primarily located in urban areas. The focus is on acquiring undervalued properties, enhancing them through renovations, and optimizing their value through effective leasing strategies.
2. Property Management:
- The company manages its own properties, ensuring high standards of maintenance and tenant satisfaction. Services may encompass tenant relations, regular property upkeep, and responding to tenant needs promptly to maintain occupancy rates and property values.
3. Development Projects:
- Rafael Holdings engages in the development of new commercial real estate projects. This includes planning and executing construction projects aimed at increasing its property portfolio and fulfilling market demands in prime locations.
Financial Services
1. Investment Management:
- The company has a segment focused on financial investments, which may involve deploying capital into the biotechnology sector and its real estate holdings. The investment management arm analyzes market trends and identifies strategic investment opportunities to enhance shareholder value.
2. Funding for Startups:
- Through its biotechnology and investment divisions, Rafael Holdings might offer funding and support for early-stage biotech startups. This involvement can aid in leveraging innovative ideas while potentially generating returns on investment as these startups mature.
Future Directions
Rafael Holdings focuses on innovation within both its biotechnology and real estate segments, aiming to stay at the forefront of scientific advancements in therapeutics while prudently managing and expanding its real estate assets. The company’s commitment to research, development, and property management underlines its strategic vision for growth and diversification across sectors.
Through these varied offerings, Rafael Holdings Inc. positions itself as a multifaceted entity with opportunities for expansion and a robust portfolio aimed at creating long-term value for stakeholders and investors.
Biotechnology Segment
1. Therapeutics Development:
- Rafael Pharmaceuticals is a key component of the biotechnology segment, focusing on the development of innovative cancer treatments. The company emphasizes the use of metabolic therapies, particularly its lead drug candidate, which aims to leverage the unique metabolic processes of cancer cells to enhance therapeutic outcomes.
- The research and development pipeline includes various stages of clinical trials. The company invests in advanced therapeutic technologies targeting specific types of cancers, including pancreatic cancer and hematological malignancies.
2. Collaborations and Partnerships:
- Rafael Holdings often collaborates with academic institutions and research organizations. Such partnerships facilitate accelerated research and development processes, share expertise, and provide funding opportunities for emerging therapies.
3. Intellectual Property:
- The company holds a robust portfolio of patents covering its proprietary technologies and compounds. Intellectual property is crucial for protecting the innovations being developed and for securing competitive advantages in the biotechnology market.
Real Estate Segment
1. Real Estate Investment:
- Rafael Holdings maintains a strategic portfolio of commercial real estate properties. This includes office buildings and other facilities, primarily located in urban areas. The focus is on acquiring undervalued properties, enhancing them through renovations, and optimizing their value through effective leasing strategies.
2. Property Management:
- The company manages its own properties, ensuring high standards of maintenance and tenant satisfaction. Services may encompass tenant relations, regular property upkeep, and responding to tenant needs promptly to maintain occupancy rates and property values.
3. Development Projects:
- Rafael Holdings engages in the development of new commercial real estate projects. This includes planning and executing construction projects aimed at increasing its property portfolio and fulfilling market demands in prime locations.
Financial Services
1. Investment Management:
- The company has a segment focused on financial investments, which may involve deploying capital into the biotechnology sector and its real estate holdings. The investment management arm analyzes market trends and identifies strategic investment opportunities to enhance shareholder value.
2. Funding for Startups:
- Through its biotechnology and investment divisions, Rafael Holdings might offer funding and support for early-stage biotech startups. This involvement can aid in leveraging innovative ideas while potentially generating returns on investment as these startups mature.
Future Directions
Rafael Holdings focuses on innovation within both its biotechnology and real estate segments, aiming to stay at the forefront of scientific advancements in therapeutics while prudently managing and expanding its real estate assets. The company’s commitment to research, development, and property management underlines its strategic vision for growth and diversification across sectors.
Through these varied offerings, Rafael Holdings Inc. positions itself as a multifaceted entity with opportunities for expansion and a robust portfolio aimed at creating long-term value for stakeholders and investors.